These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25616716)

  • 41. Transcriptional programming of human macrophages: on the way to systems immunology.
    Schultze JL
    J Mol Med (Berl); 2015 Jun; 93(6):589-97. PubMed ID: 25877862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic adaptation of macrophages in chronic diseases.
    Di Conza G; Ho PC
    Cancer Lett; 2018 Feb; 414():250-256. PubMed ID: 29175462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes.
    Barton BE
    Expert Opin Ther Targets; 2005 Aug; 9(4):737-52. PubMed ID: 16083340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Countering inflammatory signals in obesity.
    Reilly SM; Saltiel AR
    Nat Immunol; 2014 May; 15(5):410-1. PubMed ID: 24747704
    [No Abstract]   [Full Text] [Related]  

  • 45. The good, the bad, and the ugly of interleukin-6 signaling.
    Fuster JJ; Walsh K
    EMBO J; 2014 Jul; 33(13):1425-7. PubMed ID: 24850773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives.
    Španko M; Strnadová K; Pavlíček AJ; Szabo P; Kodet O; Valach J; Dvořánková B; Smetana K; Lacina L
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin 6 as an energy allocator in muscle tissue.
    Kistner TM; Pedersen BK; Lieberman DE
    Nat Metab; 2022 Feb; 4(2):170-179. PubMed ID: 35210610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unravelling the broader complexity of IL-6 involvement in health and disease.
    Jenkins RH; Hughes STO; Figueras AC; Jones SA
    Cytokine; 2021 Dec; 148():155684. PubMed ID: 34411990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer.
    Naugler WE; Karin M
    Trends Mol Med; 2008 Mar; 14(3):109-19. PubMed ID: 18261959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The metabolism-modulating activity of IL-17 signaling in health and disease.
    Bechara R; McGeachy MJ; Gaffen SL
    J Exp Med; 2021 May; 218(5):. PubMed ID: 33822846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The hormetic and hermetic role of IL-6.
    Forcina L; Franceschi C; Musarò A
    Ageing Res Rev; 2022 Sep; 80():101697. PubMed ID: 35850167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-6 as a "metabolic hormone".
    Ghanemi A; St-Amand J
    Cytokine; 2018 Dec; 112():132-136. PubMed ID: 29983356
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of interleukin-6 in cancer progression and therapeutic resistance.
    Kumari N; Dwarakanath BS; Das A; Bhatt AN
    Tumour Biol; 2016 Sep; 37(9):11553-11572. PubMed ID: 27260630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NK cells link obesity-induced adipose stress to inflammation and insulin resistance.
    Wensveen FM; Jelenčić V; Valentić S; Šestan M; Wensveen TT; Theurich S; Glasner A; Mendrila D; Štimac D; Wunderlich FT; Brüning JC; Mandelboim O; Polić B
    Nat Immunol; 2015 Apr; 16(4):376-85. PubMed ID: 25729921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IL-6 as a keystone cytokine in health and disease.
    Hunter CA; Jones SA
    Nat Immunol; 2015 May; 16(5):448-57. PubMed ID: 25898198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukins 1 and 6 as Main Mediators of Inflammation and Cancer.
    Dmitrieva OS; Shilovskiy IP; Khaitov MR; Grivennikov SI
    Biochemistry (Mosc); 2016 Feb; 81(2):80-90. PubMed ID: 27260388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition.
    Garbers C; Aparicio-Siegmund S; Rose-John S
    Curr Opin Immunol; 2015 Jun; 34():75-82. PubMed ID: 25749511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis.
    Rath T; Billmeier U; Waldner MJ; Atreya R; Neurath MF
    Arch Toxicol; 2015 Apr; 89(4):541-54. PubMed ID: 25632846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Central insulin signaling modulates hypothalamus-pituitary-adrenal axis responsiveness.
    Chong AC; Vogt MC; Hill AS; Brüning JC; Zeltser LM
    Mol Metab; 2015 Feb; 4(2):83-92. PubMed ID: 25685696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of interleukin-6 in malignant mesothelioma.
    Abdul Rahim SN; Ho GY; Coward JI
    Transl Lung Cancer Res; 2015 Feb; 4(1):55-66. PubMed ID: 25806346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.